INS and Hyperglycemia: The effect of losartan was tested in isolation and not in combination with other antidiabetic therapies (e.g., insulin supplementation); therefore, some or many of the diabetic gene changes unaffected by losartan may represent the renal consequences of hyperglycemia, per se.